AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 152 filers reported holding AKERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,295,708 | +28.3% | 25,617 | +18.5% | 0.01% | +33.3% |
| Q2 2023 | $1,009,625 | +56.8% | 21,624 | +28.5% | 0.01% | +50.0% |
| Q1 2023 | $643,725 | -28.8% | 16,825 | +2.0% | 0.00% | -33.3% |
| Q4 2022 | $903,707 | +99.5% | 16,491 | +24.0% | 0.01% | +100.0% |
| Q3 2022 | $453,000 | +265.3% | 13,298 | +1.4% | 0.00% | +200.0% |
| Q2 2022 | $124,000 | -31.5% | 13,110 | +2.7% | 0.00% | 0.0% |
| Q1 2022 | $181,000 | -37.4% | 12,765 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $289,000 | -8.3% | 13,663 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $315,000 | -11.8% | 14,072 | -2.3% | 0.00% | +100.0% |
| Q2 2021 | $357,000 | +55.9% | 14,406 | +82.6% | 0.00% | 0.0% |
| Q1 2021 | $229,000 | +12.8% | 7,891 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $203,000 | -18.5% | 7,870 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $249,000 | +46.5% | 8,096 | +18.3% | 0.00% | 0.0% |
| Q2 2020 | $170,000 | +61.9% | 6,841 | +38.0% | 0.00% | 0.0% |
| Q1 2020 | $105,000 | +54.4% | 4,956 | +61.9% | 0.00% | – |
| Q4 2019 | $68,000 | -1.4% | 3,062 | +1.5% | 0.00% | – |
| Q3 2019 | $69,000 | – | 3,018 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $179,296 | 57.03% |
| Redmile Group, LLC | 2,632,912 | $144,283,578 | 5.90% |
| Avidity Partners Management LP | 3,825,000 | $209,610,000 | 4.54% |
| COMMODORE CAPITAL LP | 537,076 | $29,432 | 4.44% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $32,564,955 | 3.92% |
| Paradigm Biocapital Advisors LP | 604,544 | $33,129,011 | 3.89% |
| Yiheng Capital Management, L.P. | 1,468,905 | $80,495,994 | 3.56% |
| Altium Capital Management LP | 125,000 | $6,850,000 | 3.48% |
| Tri Locum Partners LP | 128,851 | $7,061,000 | 2.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 172,100 | $9,431,080 | 2.70% |